Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Shield Thera Share News (STX)
STX Share
Price
STX Share
News
STX Share
Chat
STX Share
Trades54
STX
Live RNS
STX Share
Charts
STX Level 2
Console
STX Live
Share Price
STX Broker
Ratings
STX Directors
Deals
STX Financial
Diary
STX
Fundamentals
STX Short
Positions
STX
Media
STX Company
Research
STX Company
Timeline
Share Price Information for Shield Thera (STX)
Last checked at -
Last checked at 
Intraday Shield Thera Share Chart
Shield Thera News
IN BRIEF: Shield Therapeutics prescription orders up in first quarter
Shield Therapeutics PLC - Gateshead Quays, England-based commercial stage pharmaceutical company focused on the commercialisation of its oral therapy ...
IN BRIEF: Shield Therapeutics pretax loss doubles despite revenue rise
Shield Therapeutics PLC - Gateshead Quays, England-based commercial stage pharmaceutical company focused on the commercialisation of its oral therapy ...
IN BRIEF: Shield appoints Andy Hurley as chief commercial officer
Shield Therapeutics PLC - Gateshead Quays, England-based commercial stage pharmaceutical company focused on the commercialisation of its oral therapy ...
AIM WINNERS & LOSERS: Zytronic hit by electronic component shortages
(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.
Shield Therapeutics 2022 revenue jumps on Accrufer iron tablet sales
(Alliance News) - Shield Therapeutics PLC on Thursday said revenue in 2022 rose amid a jump in sales of its Accrufer iron tablets, also known as Ferac...
TRADING UPDATES: Mobile Tornado loses CEO; DeepVerge revenue jumps
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:
Shield Therapeutics completes GBP2.6 million open offer
(Alliance News) - Shield Therapeutics PLC on Thursday said it has raised GBP2.6 million through an open offer.
Follow the stocks
